Showing results (1781-1790 of 3,030) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|April 11, 2015
Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancerFlorencia Zalazar, Paola De Luca, Kevin Gardner, et al.Current Pharmaceutical Biotechnology|April 22, 2021
Cytotoxicity, Anti-diabetic, and Hepato-protective Potential of Ajuga bracteosa-conjugated Silver Nanoparticles in Balb/c MiceSadia Nazer, Saiqa Andleeb, Shaukat Ali, et al.Current Pharmaceutical Biotechnology|July 1, 2020
Novel Therapeutic Approaches and Targets for Treatment of Chronic Urticaria: New Insights and Promising Targets for a Challenging DiseaseEmanuela Martina, Federico Diotallevi, Tommaso Bianchelli, et al.Current Pharmaceutical Biotechnology|March 31, 2023
Vitamin D Activates miR-126a-5p to Target GSK-3β and Alleviates Systemic Lupus Erythematosus in MRL/LPR MiceMin-Shu Zou, Qiu-Ju Song, Tai-Yong Yin, et al.Current Pharmaceutical Biotechnology|January 5, 2002
Monoclonal antibodies in the treatment of hematologic malignancies: radiation dosimetry aspectsM G Stabin, A B BrillCurrent Pharmaceutical Biotechnology|August 8, 2002
Management of acute and chronic open wounds: the importance of moist environment in optimal wound healingBishara S Atiyeh, John Ioannovich, Christian A Al-Amm, et al.Current Pharmaceutical Biotechnology|August 8, 2002
Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosisE K Schroeder, N de Souza, D S Santos, et al.Current Pharmaceutical Biotechnology|February 7, 2003
Inhibiting cyclin-dependent kinase/cyclin activity for the treatment of cancer and cardiovascular diseaseC Ivorra, H Samyn, M D Edo, et al.Current Pharmaceutical Biotechnology|August 3, 2001
Antibody engineering for targeted therapy of cancer: recombinant Fv-immunotoxinsR Niv, C J Cohen, G Denkberg, et al.Pageof 303